Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Apexbio Technology LLC NBQX disodium salt 479347-86-9 50mg
SDP

Catalog No. 5000091813
Encompass_Preferred

NBQX disodium salt (CAS 479347-86-9) is a selective competitive antagonist of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors a subtype of ionotropic glutamate receptors By inhibiting AMPA receptor-mediated excitatory neurotransmission NBQX disodium salt is utilized to study synaptic plasticity and excitotoxicity mechanisms This compound has been shown to exhibit neuroprotective and anticonvulsant properties in preclinical models and is widely used in research on neurological disorders such as Alzheimer s disease epilepsy and schizophrenia to elucidate the physiological and pathological roles of AMPA receptor signaling

Catalog No. 50-000-91813 Supplier Apexbio Technology LLC Supplier No. B656650
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

NBQX disodium salt (CAS 479347-86-9) is a selective competitive antagonist of -amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptors a subtype of ionotropic glutamate receptors By inhibiting AMPA receptor-mediated excitatory neurotransmission NBQX disodium salt is utilized to study synaptic plasticity and excitotoxicity mechanisms This compound has been shown to exhibit neuroprotective and anticonvulsant properties in preclinical models and is widely used in research on neurological disorders such as Alzheimer s disease epilepsy and schizophrenia to elucidate the physiological and pathological roles of AMPA receptor signaling

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.